Venture Capital

With a fresh $1.5M, Katalist aims to automate video production from script to screen. But can its AI truly replace traditional workflows and empower storytellers?

In a strategic move, industry leader Ashish Malik joins DunhamTrimmer's leadership, set to guide the firm's dominance in the booming biologicals market.

Eight top US students will join a fully funded internship in Copenhagen to learn from Denmark's world-class sustainability, forging a new path for green careers.

As digital mental health fails to deliver, employers are turning to curated networks of elite, in-person practices for deeper, more specialized care.

Kitron has secured a major €44 million order for critical energy components, highlighting its key role in powering the explosive growth of AI-driven data centers.

Formerly a green housing developer, the company is now RenX Enterprises, betting its future on the multi-billion dollar market for sustainable soils.

The AI defense firm's stock surged after announcing a share repurchase, a move reflecting deep internal confidence amid a booming defense-tech market.

Picard Medical rings the NYSE bell, but its stock's volatile journey reflects the high-stakes gamble on its next-generation artificial heart technology.

The biotech upstart will present a bold pipeline, including a head-to-head trial against a market leader and a first-in-class autoimmune eye disease therapy.

Newly public AI firm Fusemachines unveils an ambitious 2026 growth plan, but faces significant financial hurdles and deep investor skepticism.

Leveraging a fleet of vintage F-104 jets, Starfighters Space raises $40M and goes public, aiming to disrupt the small satellite launch market.

An eight-figure deal for Redwire's docking systems is set to equip The Exploration Company's Nyx capsule, marking a key step for European space autonomy.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?

A new partnership aims to build a secure battery supply chain for drones and UAMs, directly responding to US defense restrictions on Chinese tech.

Molecular Partners readies for a pivotal presentation at the J.P. Morgan conference, showcasing its next-gen DARPin therapeutics for hard-to-treat cancers.

Vision Marine secures critical funds for its electric boat ambitions, but the deal's terms raise questions about shareholder value and its financial health.

Global agency INVNT appoints its first Chief AI Officer, betting on a unique human-centric leader to navigate the AI revolution in brand storytelling.

With sweeping AGM approvals for a stock consolidation and new incentive plan, IBAT secures a strong mandate to advance its sustainable lithium extraction tech.

With a bold IPO filing, Boumarang plans to leverage hydrogen power, advanced AI, and maritime drones to challenge giants in the booming autonomous systems market.

A Utah biotech reports promising results for a novel mRNA therapy that makes cancer cells look like measles, setting the stage for crucial animal trials.